News

Scientists at Scripps Research have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come.

A discovery by scientists at Scripps Research may provide a new therapy that can stop the neurotoxin even in its more severe, advanced stages of action.

With mosquito season looming in the Northern Hemisphere, doctors and researchers are poised to take on a new round of Zika virus infections.

The Nuclear Magnetic Resonance (NMR) facility at the Florida campus of Scripps Florida is becoming one of the most advanced in South Florida, thanks to a new $600,000 grant from the National Institutes of Health.

Scripps Research Graduate Program Marks 25th Commencement with Two Honorary Degree Recipients

Three chemists from Scripps Research—Dale Boger, Jin-Quan Yu and Phil Baran—have received awards from the Royal Society of Chemistry.

“Since this is a major pathway for diseases like cancer and fibrosis, our findings add a brand-new layer of valuable information."

Scientists at Scripps Research have discovered why some cancers may reoccur after years in remission.

San Diego researchers Ardem Patapoutian and Phil Baran receive one of science’s highest honors

Scientists from the Florida campus of Scripps Research have shown that a protein helps balance nerve cell communication.

Leaders in basic and translational research at TSRI and Calibr will provide target materials and relevant know‐how to prosecute drug targets of interest.

Brain cells appear less vulnerable to DNA damage than previously thought, according to a new study led by scientists at Scripps Research.

Scientists at Scripps Research in La Jolla have revealed new clues to the wiring of the brain.

New method expected to replace textbook reactions, enable syntheses of many new candidate drugs and other molecules.

Initial demonstrations yield compounds with promise for treating COPD, cystic fibrosis and other lung disorders.

A new study led by scientists at Scripps Research could help researchers develop personalized treatments for alcoholism and alcohol use disorder.

The new funding will support a five-year project, led by Professor Michael Farzan, to bring a potential HIV vaccine closer to human clinical trials.

"HIV is treatable but not curable—this remains a disease that causes a lot of suffering."

"What we've done is get to the root cause of T1D, and this allowed us to use strategies to prevent diabetes."

Burkle is Founder and Chairman of the Ronald W. Burkle Foundation, whose mission is to positively influence people around the world and their communities.

New research suggests that meth takes advantage of the brain’s natural learning process.

The researchers believe this new understanding of anti-CRISPR proteins may eventually lead to more sophisticated and efficient tools for gene editing.

"The ability to identify the glycan fingerprint on HIV’s glycoprotein will help us develop a vaccine that matches what is found on the virus."

Dawson brings to his new role more than 25 years’ experience at Scripps Research as a student, alumnus, faculty member and associate dean.